av/casi-pharmaceuticals--big.svg

COM:CASIPHARMACEUTICALS

CASI Pharmaceuticals

  • Stock

USD

Last Close

5.29

22/11 21:00

Market Cap

87.38M

Beta: -

Volume Today

16.02K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-5.74M
-
-26.20M
356.62%
-7.21M
72.50%
-9.45M
31.18%
-10.77M
13.93%
-27.47M
155.07%
-45.36M
65.12%
-47.51M
4.74%
-35.84M
24.56%
-40.26M
12.32%
-26.94M
33.08%
depreciation and amortization
17.39K
-
48.18K
177.07%
68.38K
41.93%
66.45K
2.82%
117.78K
77.24%
1.67M
1,318.70%
2.15M
28.85%
1.96M
9.01%
1.81M
7.35%
2.42M
33.44%
3.74M
54.46%
deferred income tax
-2.04M
-
-11.76K
99.42%
-27.51K
133.87%
-5.67K
79.39%
19.89K
450.75%
325.46K
1,536.21%
1.24M
279.77%
-3.94M
418.53%
-5.20M
32.13%
stock based compensation
2.04M
-
2.19M
7.08%
1.54M
29.60%
3.00M
94.35%
650.44K
78.28%
6.12M
840.61%
7.31M
19.48%
7.82M
6.99%
7.77M
0.65%
7.01M
9.78%
change in working capital
400.88K
-
273.73K
31.72%
36.00K
86.85%
348.04K
866.81%
3.57M
926.43%
-9.78M
373.78%
4.45M
145.52%
-3.32M
174.53%
-3.22M
3.01%
-6.65M
106.65%
-7.82M
17.56%
accounts receivables
669.31K
-
-23.73K
103.54%
23.73K
200%
-1.29M
-
-3.35M
159.24%
-5.16M
53.88%
-3.17M
38.54%
2.83M
189.43%
inventory
-15.01M
-
-10.16M
32.34%
-4.63M
54.39%
-4.41M
-
3.19M
172.23%
-551K
117.29%
-4.23M
667.88%
-9.74M
130.18%
accounts payables
-102.39K
-
352.17K
443.93%
129.47K
63.24%
180.53K
39.43%
849.37K
370.49%
-1.10M
229.18%
4.00M
464.67%
-1.54M
138.49%
1.49M
196.82%
1.07M
28.50%
1.15M
7.79%
other working capital
14.85M
-
10.10M
31.95%
4.52M
55.30%
167.51K
96.29%
2.72M
1,525.54%
-8.68M
418.88%
6.16M
170.88%
-1.61M
126.19%
1M
162.03%
-315K
131.50%
-2.06M
554.92%
other non cash items
2.04M
-
19.71M
863.99%
74.95K
99.62%
26.31K
64.90%
7.48K
71.58%
553.57K
7,304.64%
6.97M
1,158.74%
19.10M
174.11%
7.83M
58.98%
16.39M
109.15%
11.05M
32.58%
net cash provided by operating activities
-3.28M
-
-4.00M
21.97%
-5.51M
37.99%
-6.02M
9.24%
-6.40M
6.29%
-28.58M
346.47%
-23.24M
18.69%
-25.89M
11.37%
-26.84M
3.69%
-21.09M
21.44%
-19.97M
5.32%
investments in property plant and equipment
-42.98K
-
-466.33K
985.11%
-25.40K
94.55%
-223.23K
779.01%
-934.70K
318.71%
-21.77M
2,229.52%
-14.02M
35.61%
-19.33M
37.85%
-15.50M
19.80%
-5.61M
63.79%
-2.24M
60.07%
acquisitions net
-20.64M
-
20M
196.89%
10K
-
purchases of investments
-14.04M
-
-83K
99.41%
-12.40M
14,842.17%
-7.42M
40.13%
-51.75M
597.02%
sales maturities of investments
-13.03M
-
172K
-
37.62M
21,773.26%
43.32M
15.15%
other investing activites
158.45K
-
20.64M
-
-6.97M
133.75%
-1.31M
81.21%
7.03M
636.97%
6.57M
6.47%
1M
84.79%
net cash used for investing activites
-42.98K
-
-466.33K
985.11%
-25.40K
94.55%
-64.79K
155.11%
-934.70K
1,342.73%
-21.77M
2,229.46%
-28.06M
28.86%
-20.72M
26.16%
-20.69M
0.14%
31.16M
250.59%
-9.67M
131.04%
debt repayment
-1.50M
-
-1.25M
16.73%
-1.55M
23.94%
-4.00M
158.46%
common stock issued
10.79M
-
28.15M
-
23.87M
15.19%
87.99M
268.61%
182K
99.79%
45.10M
24,679.67%
32.50M
27.94%
109K
-
common stock repurchased
8.65M
-
-367K
-
-251K
31.61%
-3.27M
-
-278K
91.49%
dividends paid
-367K
-
-998K
171.93%
other financing activites
-388.87K
-
-8.65M
2,124.07%
-96.51K
-
-136.84K
41.79%
4.28M
3,227.40%
24.10M
463.07%
4.55M
81.11%
-1.31M
128.78%
4.00M
405.42%
-738K
118.45%
net cash used provided by financing activities
10.40M
-
8.65M
16.85%
28.05M
-
23.73M
15.39%
92.27M
288.77%
22.05M
76.11%
47.15M
113.89%
29.64M
37.14%
-3.27M
111.02%
-907K
72.24%
effect of forex changes on cash
-8.65M
-
-1.20M
-
-1.33M
10.90%
2.90M
318.00%
-469K
116.20%
1.60M
442.00%
518K
67.71%
net change in cash
7.08M
-
-4.46M
163.00%
-5.54M
24.14%
21.96M
496.51%
16.40M
25.34%
40.71M
148.31%
-30.58M
175.12%
3.44M
111.26%
-18.36M
633.26%
8.41M
145.80%
-30.03M
457.15%
cash at beginning of period
8.05M
-
15.13M
87.99%
10.67M
29.49%
5.13M
51.91%
27.09M
428.01%
43.49M
60.52%
84.20M
93.62%
53.62M
36.32%
57.06M
6.42%
38.70M
32.17%
47.11M
21.72%
cash at end of period
15.13M
-
10.67M
29.49%
5.13M
51.91%
27.09M
428.01%
43.49M
60.52%
84.20M
93.62%
53.62M
36.32%
57.06M
6.42%
38.70M
32.17%
47.11M
21.72%
17.08M
63.74%
operating cash flow
-3.28M
-
-4.00M
21.97%
-5.51M
37.99%
-6.02M
9.24%
-6.40M
6.29%
-28.58M
346.47%
-23.24M
18.69%
-25.89M
11.37%
-26.84M
3.69%
-21.09M
21.44%
-19.97M
5.32%
capital expenditure
-42.98K
-
-466.33K
985.11%
-25.40K
94.55%
-223.23K
779.01%
-934.70K
318.71%
-21.77M
2,229.52%
-14.02M
35.61%
-19.33M
37.85%
-15.50M
19.80%
-5.61M
63.79%
-2.24M
60.07%
free cash flow
-3.32M
-
-4.46M
34.44%
-5.54M
24.14%
-6.25M
12.77%
-7.34M
17.46%
-50.36M
586.36%
-37.26M
26.00%
-45.21M
21.33%
-42.34M
6.35%
-26.70M
36.94%
-22.21M
16.82%

All numbers in USD (except ratios and percentages)